WO2012042467A3 - A magnetic hybrid hydrogel - Google Patents
A magnetic hybrid hydrogel Download PDFInfo
- Publication number
- WO2012042467A3 WO2012042467A3 PCT/IB2011/054240 IB2011054240W WO2012042467A3 WO 2012042467 A3 WO2012042467 A3 WO 2012042467A3 IB 2011054240 W IB2011054240 W IB 2011054240W WO 2012042467 A3 WO2012042467 A3 WO 2012042467A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nanoparticles
- magnetic
- acid
- hydrogel
- combinations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
- C08B15/005—Crosslinking of cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B11/00—Preparation of cellulose ethers
- C08B11/02—Alkyl or cycloalkyl ethers
- C08B11/04—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
- C08B11/10—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals
- C08B11/12—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals substituted with carboxylic radicals, e.g. carboxymethylcellulose [CMC]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
- C08J3/246—Intercrosslinking of at least two polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
- C08J2301/08—Cellulose derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Materials Engineering (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Dispersion Chemistry (AREA)
- Nanotechnology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Composite Materials (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
The present invention relates to a magnetic hybrid hydrogel comprising a biocompatible, bioreabsorbable polymer crosslinked with magnetic particles which act as crosslinking agents. The polymer can be a polysaccharide chosen from among carboxymethyl cellulose, hyaluronic acid, chitin, alginic acid, alginates, chitosan or combinations thereof; or else a synthetic polymer chosen from among polyacrylic acid, polylactic acid, polyvinylamine or combinations thereof. The magnetic nanoparticles can be nanoparticles of Fe2C>3, Fe304, Fe204 or else mixed nanoparticles of Fe and Co, Mn or Zn, preferably functionalized with -NH2, - COOH,-OH,-SH groups. The hydrogel is used in oncological medicine for the targeted administration and controlled release of a drug, or else in regenerative medicine for applications of cells or other factors for the purpose of regenerating or repairing a tissue or organ.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT001752A ITMI20101752A1 (en) | 2010-09-27 | 2010-09-27 | HYDROGEL MAGNETIC HYBRID |
ITMI2010A001752 | 2010-09-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012042467A2 WO2012042467A2 (en) | 2012-04-05 |
WO2012042467A3 true WO2012042467A3 (en) | 2012-07-12 |
Family
ID=43706452
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2011/054240 WO2012042467A2 (en) | 2010-09-27 | 2011-09-27 | A magnetic hybrid hydrogel |
Country Status (2)
Country | Link |
---|---|
IT (1) | ITMI20101752A1 (en) |
WO (1) | WO2012042467A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015148512A1 (en) | 2014-03-24 | 2015-10-01 | Qt Holdings Corp | Shaped articles including hydrogels and methods of manufacture and use thereof |
US9790467B2 (en) * | 2015-09-22 | 2017-10-17 | Qt Holdings Corp | Methods and compositions for activation or expansion of T lymphocytes |
KR20190138646A (en) * | 2017-03-20 | 2019-12-13 | 큐티 홀딩스 코포레이션 | Methods and Compositions for the Regulation of Immune Cells |
CN108992703A (en) * | 2018-08-17 | 2018-12-14 | 佛山市森昂生物科技有限公司 | A kind of preparation method of highly-breathable medical gel material |
CN110384655A (en) * | 2019-08-30 | 2019-10-29 | 浙江理工大学 | A kind of preparation method of high-biocompatibility pharmaceutical carrier hydrogel |
CN113416319B (en) * | 2021-05-25 | 2022-07-12 | 丽水学院 | Ultraviolet light blocking type hydrogel containing immobilized nanoparticles and preparation method thereof |
CN113559909A (en) * | 2021-07-27 | 2021-10-29 | 陕西科技大学 | Magnetic LDO/CN composite catalyst and preparation method and application thereof |
CN113501976B (en) * | 2021-08-11 | 2022-06-03 | 电子科技大学 | Preparation method of electromagnetic shielding self-repairing skin-friendly hydrogel |
CN113730639B (en) * | 2021-09-15 | 2022-05-06 | 上海大学 | Magnetic dressing and preparation method and application thereof |
KR20230097904A (en) * | 2021-12-24 | 2023-07-03 | 서울대학교산학협력단 | Nanocomposite for drug delivery |
CN116809032B (en) * | 2023-07-03 | 2024-06-04 | 中国热带农业科学院南亚热带作物研究所 | Sulfhydryl modified chitosan porous microsphere and preparation method and application thereof |
-
2010
- 2010-09-27 IT IT001752A patent/ITMI20101752A1/en unknown
-
2011
- 2011-09-27 WO PCT/IB2011/054240 patent/WO2012042467A2/en active Application Filing
Non-Patent Citations (6)
Title |
---|
BARAKAT NAHLA S: "Magnetically modulated nanosystems: a unique drug-delivery platform", NANOMEDICINE,, vol. 4, no. 7, 1 October 2009 (2009-10-01), pages 799 - 812, XP009145958 * |
DANIEL-DA-SILVA ANA L ET AL: "Biofunctionalized magnetic hydrogel nanospheres of magnetite and kappa-carrageenan.", NANOTECHNOLOGY 2 SEP 2009 LNKD- PUBMED:19671980, vol. 20, no. 35, 2 September 2009 (2009-09-02), pages 355602, XP020164712, ISSN: 1361-6528 * |
FUHRER ROLAND ET AL: "Crosslinking metal nanoparticles into the polymer backbone of hydrogels enables preparation of soft, magnetic field-driven actuators with muscle-like flexibility", SMALL, WILEY - VCH VERLAG GMBH & CO. KGAA, DE, vol. 5, no. 3, 1 March 2009 (2009-03-01), pages 383 - 388, XP009145959, ISSN: 1613-6810 * |
GUPTA A K ET AL: "Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 26, no. 18, 1 January 2005 (2005-01-01), pages 3995 - 4021, XP002542497, ISSN: 0142-9612, [retrieved on 20041210], DOI: DOI:10.1016/J.BIOMATERIALS.2004.10.012 * |
LAPOINTE J ET AL: "Thermoresponsive hydrogel with embedded magnetic nanoparticles for the implementation of shrinkable medical microrobots and for targeting and drug delivery applications", ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, 2009. EMBC 2009. ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE, IEEE, PISCATAWAY, NJ, USA, 3 September 2009 (2009-09-03), pages 4246 - 4249, XP031638186, ISBN: 978-1-4244-3296-7 * |
MEENACH SAMANTHA A ET AL: "Hydrogel Nanocomposites: Biomedical Applications, Biocompatibility, and Toxicity Analysis", SAFETY OF NANOPARTICLES: FROM MANUFACTURING TO MEDICAL APPLICATIONS SPRINGER, 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES SERIES : NANOSTRUCTURE SCIENCE AND TECHNOLOGY, 2009, pages 131 - 157, XP009145993 * |
Also Published As
Publication number | Publication date |
---|---|
ITMI20101752A1 (en) | 2012-03-28 |
WO2012042467A2 (en) | 2012-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012042467A3 (en) | A magnetic hybrid hydrogel | |
Kaith et al. | Hydrogels: synthesis, classification, properties and potential applications—a brief review | |
Rodríguez-Rodríguez et al. | Composite hydrogels based on gelatin, chitosan and polyvinyl alcohol to biomedical applications: A review | |
Jafari et al. | Magnetic κ-carrageenan/chitosan/montmorillonite nanocomposite hydrogels with controlled sunitinib release | |
Chen et al. | Ultratough, self-healing, and tissue-adhesive hydrogel for wound dressing | |
Abednejad et al. | Hyaluronic acid/carboxylated Zeolitic Imidazolate Framework film with improved mechanical and antibacterial properties | |
Kodoth et al. | Pectin-based silver nanocomposite film for transdermal delivery of Donepezil | |
US11168183B2 (en) | Method for the production of hydrogel comprising chitosan and negatively charged polyelectrolytes, and cellular, porous material resulting from said hydrogel | |
Raveendran et al. | Smart carriers and nanohealers: A nanomedical insight on natural polymers | |
Kumar et al. | Ciprofloxacin loaded genipin cross-linked chitosan/heparin nanoparticles for drug delivery application | |
Grumezescu et al. | Synthesis, characterization and in vitro assessment of the magnetic chitosan–carboxymethylcellulose biocomposite interactions with the prokaryotic and eukaryotic cells | |
Wang et al. | Novel synthesis of mussel inspired and Fe3+ induced pH-sensitive hydrogels: Adhesion, injectable, shapeable, temperature properties, release behavior and rheological characterization | |
Chen et al. | Synergistic enhancement of hemostatic performance of mesoporous silica by hydrocaffeic acid and chitosan | |
Buwalda | Bio-based composite hydrogels for biomedical applications | |
Jin et al. | Alginate-based composite microspheres coated by berberine simultaneously improve hemostatic and antibacterial efficacy | |
Choudhary et al. | Fabrication of chitosan-reinforced multifunctional graphene nanocomposite as antibacterial scaffolds for hemorrhage control and wound-healing application | |
WO2010005723A3 (en) | Drug loaded polymeric nanoparticles and methods of making and using same | |
NZ599527A (en) | Fragmented hydrogels | |
WO2012166923A3 (en) | Drug loaded polymeric nanoparticles and methods of making and using same | |
Liu et al. | Antibacterial activity and drug loading of moxifloxacin-loaded poly (vinyl alcohol)/chitosan electrospun nanofibers | |
Khoshnood et al. | The potential impact of polyethylenimine on biological behavior of 3D-printed alginate scaffolds | |
Xin et al. | Cytotoxicity and antibacterial ability of scaffolds immobilized by polysaccharide/layered silicate composites | |
Liang et al. | Novel antibacterial cellulose diacetate-based composite 3D scaffold as potential wound dressing | |
Zhang et al. | Application of polyvinyl alcohol/chitosan copolymer hydrogels in biomedicine: A review | |
Rozan et al. | The complex hydrogel based on diatom biosilica and hydroxybutyl chitosan for wound healing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11781611 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11781611 Country of ref document: EP Kind code of ref document: A2 |